Hindustan Life Sciences (I) Limited
About Hindustan Life Sciences (I) Limited
Data last updated:
Hindustan Life Sciences (I) Limited is a public limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U33110MP2014PLC032981. Its GSTIN is 23AADCH4978E1ZL (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It was formerly known as Hindustan Life Sciences (I) Private Limited. It is led by directors including Lalit Narayan Mishra and Rishav Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 226 Swasthya Nagar Sukhliya, Indore, Madhya Pradesh, India – 452010.
As per the financials filed for FY 2025, the company reported a revenue of ₹44.94 Lakh. For the same year it recorded a net profit of ₹74,549 (net margin 1.7%) and EBITDA of ₹1.26 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Hindustan Life Sciences (I) has one previous CIN (Corporate Identification Number): U33110MP2014PTC032981. The current CIN is U33110MP2014PLC032981, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33110MP2014PLC032981 | Current |
| U33110MP2014PTC032981 | Previous |
Contact details
Hindustan Life Sciences (I) Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address226 Swasthya Nagar Sukhliya, Indore, Madhya Pradesh, India – 452010
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hindustan Life Sciences (I) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hindustan Life Sciences (I) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hindustan Life Sciences (I) Limited, buy the company report.
Financials of Hindustan Life Sciences (I) Limited
FY 2025 filings availableHindustan Life Sciences (I) Limited reported revenue of ₹44.94 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years. EBITDA fell 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹74,549 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hindustan Life Sciences (I) Limited, buy the company report.
Board of directors of Hindustan Life Sciences (I) Limited
Hindustan Life Sciences (I) has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lalit Narayan Mishra | Director | 30 Jul 2014 | 12 Years 2 Months | Current |
| Rishav Mishra | Director | 20 Sep 2021 | 5 Years 1 Months | Current |
| Ranjana Mishra | Director | 30 Jul 2014 | 12 Years 2 Months | Current |
Peer comparison
Hindustan Life Sciences (I) Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Laso Healthcare Private Limited | ₹45 Lakh (FY 2024) | -44.0% | Chennai, Tamil Nadu, India | |||
| Wellgone Nutraceuticals Private Limited | ₹44.98 Lakh (FY 2025) | 3.0% | Ambala, Haryana, India | |||
| Hindustan Life Sciences (I) Limitedthis company | ₹44.94 Lakh (FY 2025) | ₹74,549 | 1.7% | Indore, Madhya Pradesh, India | ||
| Dhruvtara Lifesciences Private Limited | ₹44.87 Lakh (FY 2025) | 172.0% | Gandhinagar, Gujarat, India |
To see the full peer comparison of Hindustan Life Sciences (I) Limited, buy the company report.
Auditor
Hindustan Life Sciences (I) Limited is audited by NAHAR V & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAHAR V & CO | FY 2023 | 010443C |
Shareholding
The shareholding of Hindustan Life Sciences (I) Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hindustan Life Sciences (I) Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Feb 2023 | 100695475 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Hindustan Life Sciences (I) Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hindustan Life Sciences (I) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hindustan Life Sciences (I) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AADCH4978E1ZL | Madhya Pradesh | Active | 01 Aug 2018 |
To see the full GST registrations and return filing status of Hindustan Life Sciences (I) Limited, buy the company report.
Recent activity
Hindustan Life Sciences (I) Limited has 7 board changes on record since 2014: 5 appointments and 2 cessations. The latest: Lalitsingh Nahar ceased to be Director on 20 Sep 2021.
Frequently asked questions
Hindustan Life Sciences (I) is an active public limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 July 2014 (12+ years old) and is registered under CIN U33110MP2014PLC032981.
Hindustan Life Sciences (I) has 3 current directors:
- Lalit Narayan Mishra - Director
- Rishav Mishra - Director
- Ranjana Mishra - Director
The latest financial statements of Hindustan Life Sciences (I) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hindustan Life Sciences (I) is 23AADCH4978E1ZL, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Hindustan Life Sciences (I) is U33110MP2014PLC032981. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hindustan Life Sciences (I) was incorporated on 30 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Hindustan Life Sciences (I) by revenue are Laso Healthcare Private Limited, Wellgone Nutraceuticals Private Limited, Dhruvtara Lifesciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Lalitsingh Nahar ceased to be Director on 20 Sep 2021. Rishav Mishra was appointed as Director on 20 Sep 2021. Harish Chandra Mishra ceased to be Director on 11 Jan 2021. Hindustan Life Sciences (I) has 7 board changes on record in total.
The registered office of Hindustan Life Sciences (I) is at 226 Swasthya Nagar Sukhliya, Indore, Madhya Pradesh, India – 452010.
Hindustan Life Sciences (I) operates in the pharma industry, in the drug formulation and development segment.
Hindustan Life Sciences (I) has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.